Trial intelligence / Profile preview

Liposomal vs Plain Bupivacaine in Minimally Invasive Surgery

NCT02875288Completed

Sponsor
Naval Medical Center San Diego
Start
Dec 2015
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Naval Medical Center San Diego. Primary endpoint: Total post operative narcotic use in morphine equivalents at 14 days. Started Dec 2015; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02875288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02875288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call